| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VPH.2008.11.006 |
| P698 | PubMed publication ID | 19068239 |
| P50 | author | Han-Gon Choi | Q88992571 |
| P2093 | author name string | Keon Wook Kang | |
| Mi-Kyoung Kwak | |||
| Jung-Ae Kim | |||
| Shaker A Mousa | |||
| Chul Soon Yong | |||
| Jong Tae Kim | |||
| Byung Chul Park | |||
| Eung-Seok Lee | |||
| Jong-Suk Lee | |||
| Su-Young Park | |||
| P2860 | cites work | Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro | Q44730791 |
| Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest | Q45097073 | ||
| Activation of the Nrf2-antioxidant system by a novel cyclooxygenase-2 inhibitor furan-2-yl-3-pyridin-2-yl-propenone: implication in anti-inflammatory function by Nrf2 activator | Q46543650 | ||
| In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy | Q46549052 | ||
| Potent analgesic and anti-inflammatory activities of 1-furan-2-yl-3-pyridin-2-yl-propenone with gastric ulcer sparing effect | Q46930936 | ||
| Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay | Q50802433 | ||
| EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. | Q51191354 | ||
| HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. | Q52035056 | ||
| Prognostic Correlation of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in 1307 Primary Breast Cancers | Q58352346 | ||
| A simple procedure for the long-term cultivation of chicken embryos | Q68879935 | ||
| NADPH oxidase activity is required for endothelial cell proliferation and migration | Q73303463 | ||
| Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells | Q74787983 | ||
| COX-2 and colon cancer | Q77609058 | ||
| Assignment of hydrogen-bond structure in a ligand-nucleobase complex inside duplex DNA: combined use of quantum chemical calculations and 15N NMR experiments | Q79410457 | ||
| Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells | Q83228101 | ||
| JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats | Q24803701 | ||
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Inhibition of the arachidonic acid metabolism blocks endothelial cell migration and induces apoptosis | Q28168477 | ||
| The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells | Q28257153 | ||
| Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 | ||
| Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis | Q28609623 | ||
| Cyclooxygenases 1 and 2 | Q29615645 | ||
| Relative thromboembolic risks associated with COX-2 inhibitors | Q30437125 | ||
| The coxibs, selective inhibitors of cyclooxygenase-2. | Q34086325 | ||
| Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential | Q36085224 | ||
| COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation | Q36229672 | ||
| Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now? | Q36304331 | ||
| Cyclooxygenase-2 inhibition and coagulation | Q36512075 | ||
| Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo | Q37360588 | ||
| Inhibition of nitric oxide and tumor necrosis factor-alpha (TNF-alpha) production by propenone compound through blockade of nuclear factor (NF)-kappa B activation in cultured murine macrophages | Q38517488 | ||
| Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities | Q38517576 | ||
| Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells | Q39983438 | ||
| 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP. | Q40132159 | ||
| VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway | Q40309518 | ||
| Host cyclooxygenase-2 modulates carcinoma growth. | Q40365112 | ||
| Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes | Q41168770 | ||
| Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis | Q41372654 | ||
| Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing | Q41705080 | ||
| Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells | Q42524468 | ||
| Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. | Q43806613 | ||
| Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen | Q44518952 | ||
| Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism | Q44659688 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| P304 | page(s) | 123-131 | |
| P577 | publication date | 2008-11-28 | |
| P1433 | published in | Vascular Pharmacology | Q7916446 |
| P1476 | title | The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling | |
| P478 | volume | 50 |
| Q38851733 | Engineering of a disulfide loop instead of a Zn binding loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endostatin: Mechanistic and therapeutic insights |
| Q64245283 | Enhanced Therapeutic Effect of RGD-Modified Polymeric Micelles Loaded With Low-Dose Methotrexate and Nimesulide on Rheumatoid Arthritis |
| Q57821405 | Is Furazolidone Therapy for Helicobacter pylori Effective and Safe? |
| Q38558587 | Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety |
| Q39643610 | Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis |
| Q38974193 | The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis |
| Q36589476 | The anti-proliferative and anti-angiogenic effect of the methanol extract from brittle star |
| Q39230827 | δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF. |
Search more.